Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nihon Schering Ties Up with Daiichi Radioisotope
July 17, 2006
- ADR Offers New Method of Solving Patent Disputes
July 17, 2006
- BUSINESS NEWS IN BRIEF
July 17, 2006
- Council Proposes Cuts of \11.4-14.3 Tril. Over Next 5 Years
July 10, 2006
- SEMINAR
July 10, 2006
- Otsuka's Mozavaptan Recommended for Approval
July 10, 2006
- Asahi Kasei Licenses Fasudil to CoTherix
July 10, 2006
- Proposed Vision Calls For Support of Vaccine Development
July 10, 2006
- SURVEY 2 articles
July 10, 2006
- HPB Sets Up Another Study Group to Promote Clinical Trials
July 10, 2006
- Oncology Div. Preparing to Launch Nexavar: Bayer Yakuhin
July 10, 2006
- REGULATORY NEWS IN BRIEF
July 10, 2006
- R&D Management Company More Efficient Than Council: Eisai
July 10, 2006
- Pfizer to Sell CHC Business to J&J for US$16.6 Bil.
July 10, 2006
- Eisai Licenses SERM to Radius
July 10, 2006
- OTC Version of Teijin's Aftach Recommended for Approval
July 10, 2006
- Takeda Ordered to Pay \57 Bil. in Additional Taxes
July 10, 2006
- SELF-MEDICATION NEWS IN BRIEF
July 10, 2006
- Shareholders Express Concern over Future Strategies
July 10, 2006
- R&D NEWS IN BRIEF
July 10, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…